HILS - Hillstream BioPharma, Inc. Stock Price, Fair Value and News

1994.40USD+166.40 (+9.10%)Market Closed

Market Summary

USD1994.40+166.40

Market Closed

9.10%

HILS Stock Price

View Fullscreen

HILS RSI Chart

HILS Valuation

Market Cap

22.5B

Price/Earnings (Trailing)

-2.5K

Price/Sales (Trailing)

104.0K

Price/Free Cashflow

-3.4K

HILS Price/Sales (Trailing)

HILS Profitability

Return on Equity

-126.07%

Return on Assets

-100%

Free Cashflow Yield

-0.03%

HILS Fundamentals

HILS Revenue

Revenue (TTM)

216.3K

Rev. Growth (Qtr)

66.1%

HILS Earnings

Earnings (TTM)

-8.9M

Earnings Growth (Yr)

16.08%

Earnings Growth (Qtr)

8.8%

Breaking Down HILS Revenue

Last 7 days

-4.8%

Last 30 days

-0.8%

Last 90 days

9.8%

Trailing 12 Months

465779.9%

How does HILS drawdown profile look like?

HILS Financial Health

Current Ratio

4.84

HILS Investor Care

Shares Dilution (1Y)

2.39%

Diluted EPS (TTM)

-4.15

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	216.3K	0	0	0
2023	0	0	0	152.6K

Get all data in R, Python etc through our Historical Stock Data APIs

About Hillstream BioPharma, Inc.

Hillstream BioPharma, Inc., a pre-clinical biotechnology company, develops novel therapeutic candidates targeting ferroptosis, an anti-cancer mechanism resulting in iron mediated cell death (IMCD) and targeted immuno-oncology novel biologics for the treatment drug resistant cancers. The company's product candidate is HSB-1216, an IMCD inducer targeting solid tumors. It also develops HSB-3215, an anti-HER2 monoclonal antibody candidate; and HSB-1940, a Quatrabody that is a proprietary IO biologic in development targeting PD-1. The company was incorporated in 2017 and is based in Bridgewater, New Jersey.

CEO	Mr. Randy D. Milby MBA
WEBSITE	hillstreambio.com
INDUSTRY	Biotechnology
EMPLOYEES	1

Hillstream BioPharma, Inc. Frequently Asked Questions

What is the ticker symbol for Hillstream BioPharma, Inc.? What does HILS stand for in stocks?

HILS is the stock ticker symbol of Hillstream BioPharma, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Hillstream BioPharma, Inc. (HILS)?

As of Tue Apr 30 2024, market cap of Hillstream BioPharma, Inc. is 22.49 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of HILS stock?

You can check HILS's fair value in chart for subscribers.

Is Hillstream BioPharma, Inc. a good stock to buy?

The fair value guage provides a quick view whether HILS is over valued or under valued. Whether Hillstream BioPharma, Inc. is cheap or expensive depends on the assumptions which impact Hillstream BioPharma, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for HILS.

What is Hillstream BioPharma, Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Tue Apr 30 2024, HILS's PE ratio (Price to Earnings) is -2531.22 and Price to Sales (PS) ratio is 104.01 Thousand. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. HILS PE ratio will change depending on the future growth rate expectations of investors.